- Health Canada authorizes long-awaited drug to slow early-stage Alzheimer’s disease CTV News
- Drug to slow early-stage Alzheimer’s disease approved by Health Canada CBC
- Excitement around Alzheimer’s treatment tempered by questions about efficacy, accessibility The Globe and Mail
- How Investors Are Reacting To Eisai (TSE:4523) Securing Canadian Approval for Leqembi Alzheimer’s Therapy simplywall.st
- ‘An important milestone:’ Canada approves expensive new drug that can slow Alzheimer’s disease CTV News